Jacks Tyler 4
4 · AMGEN INC · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
AMGEN Director Tyler Jacks Receives 665 RSUs
What Happened
Tyler Jacks, a director of Amgen Inc. (AMGN), was awarded 665 restricted stock units (RSUs) on May 19, 2026. The RSUs show an acquisition price of $0.00 (total reported cash consideration $0) and, per the filing, vested immediately. Vested RSUs are paid in shares on a one-to-one basis and may be deferred by the director according to an elected deferral schedule.
Key Details
- Transaction date: 2026-05-19; Form 4 filed: 2026-05-21 (appears timely within the 2-business-day Form 4 window).
- Transaction type/code: Award/Grant (A).
- Amount: 665 RSUs acquired at $0.00 (reported value $0).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnote F1: RSUs granted under Amgen’s 2009 Director Incentive Program and vested immediately; vested RSUs are settled one-for-one in common stock and may be deferred.
- Footnote F2: The filing also references 2,975 dividend equivalents (DEs) credited to unvested RSUs; DEs are paid out in shares per the vesting schedule (plus cash for any fractional share).
Context
This was a compensation award to a director, not an open-market purchase or sale. Awards and vested RSUs represent company compensation and do not directly signal a director’s buying or selling intent in the public market. Dividend equivalents noted in the footnotes are additional credits tied to unvested RSUs and will convert to shares according to vesting terms.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-05-19+665→ 18,284 total
Footnotes (2)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
- [F2]These shares include 2,975 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.